首页> 外文期刊>Journal of Labelled Compounds and Radiopharmaceuticals >Synthesis, radiolabeling and evaluation of a new positively charged ~(99m)Tc-labeled fatty acid derivative for myocardial imaging
【24h】

Synthesis, radiolabeling and evaluation of a new positively charged ~(99m)Tc-labeled fatty acid derivative for myocardial imaging

机译:用于心肌成像的新型带电〜(99M)TC标记的脂肪酸衍生物的合成,放射性标记和评价

获取原文
获取原文并翻译 | 示例
           

摘要

~(123)I-Iabeled fatty acids and ~(18)F-FDG are used as metabolic markers for detecting myocardial abnormalities. However, a ~(99m)Tc-based molecule may find wider application. In the present work, a new ~(99m)Tc-labeled, uni-positively charged, 16-carbon fatty acid has been prepared and evaluated in normal Swiss mice. The results are then compared with the neutral analogue reported earlier. A 16-cysteinyl hexadecanoic acid conjugate was synthesized in a six-step synthetic procedure starting with 16-bromohexadecanoic acid. The ligand upon incubation with [~(99m)TcN(PNP6)]~(2+) core formed the required positively charged complex in approx 85% yield. The complex, which was obtained as a mixture of syn-anti isomers, was purified by HPLC and the major fraction was used for in vivo studies in Swiss mice. The biodistribution studies in Swiss mice showed initial uptake similar to ~(125)I-IPPA followed by rapid clearance from the myocardium till 10 min p.i. Thereafter, the rate of clearance was significantly decreased, an observation reported earlier for positively charged fatty acid complexes. In terms of absolute uptake, the positively charged complex performed better than the neutral analogue reported earlier. The positively charged fatty acid complexes, prepared using [~(99m)TcN(PNP)]~(2+) core, seems to be better candidates for the development of myocardial metabolic tracers than their neutral counterparts.
机译:〜(123)I-Iabeled脂肪酸和〜(18)F-FDG用作代谢标志物,用于检测心肌异常。但是,〜(99米)的基于TC的分子可能会找到更广泛的应用。在本作工作中,在正常的瑞士小鼠中制备和评估了新〜(99米)的标记,单极电荷的16-碳脂肪酸。然后将结果与前面报道的中性模数进行比较。在以16-溴己二烷酸开始的六步合成程序中合成16-胱烯基十六烷酸缀合物。与[〜(99M)TCN(PNP6)]〜(2+)核孵育后的配体形成了所需的正电荷的复合物,其约为85%的产率。通过HPLC纯化作为同步异构体的混合物获得的复合物,主要部分用于瑞士小鼠的体内研究。瑞士小鼠的生物分布研究表明,与〜(125)I-IPPA相似的初始摄取,然后从心肌快速清关至10分钟P.I.此后,清除率显着降低,前面报告的用于带正电荷的脂肪酸复合物的观察结果。就绝对吸收而言,正电荷的复合物比前面报告的中性模拟表现更好。使用[〜(99米)TCN(PNP)]〜(2+)核心制备的带正电荷的脂肪酸复合物似乎是候选心肌代谢示踪剂的候选者,而不是其中性对应物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号